Contributed By Walder Wyss Ltd
Advertising of medicines on the internet without any access restriction is considered to be advertising to the public (cf. Article 15 lit. c AWV). Therefore, the rules applicable to advertising to the public apply.
If articles and contributions from other media about a company or its medicines are offered on the website of that company (press reviews), the content of these articles and contributions are attributed to that company in terms of advertising law. Therefore, the provisions of the AWV are fully applicable to such press reviews (Swissmedic Journal 8/2006, p. 796 et seqq.).
In Switzerland, advertising on social media must comply with the general rules applicable to advertising on the internet. Therefore, the same restrictions apply as to advertising on the internet.
Advertising to healthcare professionals may not be made publicly accessible on the internet. It must be provided with an appropriate technical and password-protected access restriction and may only be made available to doctors, dentists, veterinarians, chiropractors, apothecaries, druggists and other persons authorised to dispense or apply medicines according to Article 24 and 25 HMG and Article 52 para. 2 of the Ordinance on Medicinal Products (VAM; Article 5a AWV).